Mette Kirstine Agger - Jun 3, 2025 Form 4 Insider Report for scPharmaceuticals Inc. (SCPH)

Role
Director
Signature
/s/ John H. Tucker, attorney-in-fact
Stock symbol
SCPH
Transactions as of
Jun 3, 2025
Transactions value $
$0
Form type
4
Date filed
6/5/2025, 05:31 PM
Previous filing
Jun 27, 2024
Next filing
Jun 30, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Agger Mette Kirstine Director C/O SCPHARMACEUTICALS INC, 25 BURLINGTON MALL ROAD, SUITE 203, BURLINGTON /s/ John H. Tucker, attorney-in-fact 2025-06-05 0001722234

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCPH Stock Option (Right to Buy) Award $0 +30K $0.00 30K Jun 3, 2025 Common Stock 30K $3.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests in full upon the earlier of (i) June 3, 2026, or (ii) the next annual meeting of the Issuer's stockholders.